DNAIllumina posts 78% revenue growth as cancer, DNA testing ramp back up – FierceBiotech admin DNA sequencing, Earnings, Fierce Biotech Homepage, Grail, Illumina, MedTech, mergers and acquisitions 0 Comments February 20, 2022 Tweet Illumina posts 78% revenue growth as cancer, DNA testing ramp back up FierceBiotech